organophosphonates has been researched along with Chlamydia Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huston, WM; Lott, WB; Marsh, JW; Ong, VA; Timms, P; Tyndall, JD | 1 |
| Gaydos, CA; Hardick, A; Holden, J; Quinn, TC; Rizzo-Price, P; Wood, BJ | 1 |
1 review(s) available for organophosphonates and Chlamydia Infections
| Article | Year |
|---|---|
CtHtrA: the lynchpin of the chlamydial surface and a promising therapeutic target.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Chlamydia Infections; Chlamydia trachomatis; Dipeptides; Humans; Models, Biological; Models, Molecular; Organophosphonates; Protease Inhibitors; Serine Endopeptidases; Virulence Factors | 2017 |
1 other study(ies) available for organophosphonates and Chlamydia Infections
| Article | Year |
|---|---|
The microbicide tenofovir does not inhibit nucleic acid amplification tests for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine samples.
Topics: Adenine; Anti-Infective Agents; Chlamydia Infections; Chlamydia trachomatis; Female; Gonorrhea; Humans; Male; Neisseria gonorrhoeae; Nucleic Acid Amplification Techniques; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir; Urine | 2008 |